The CAIRO4 study is a clinical trial designed to investigate the impact of upfront primary tumor resection (PTR) on overall survival (OS) in patients with…
IBI363 is an experimental drug designed to tackle a significant challenge in cancer immunotherapy: the resistance of certain tumors to immune checkpoint inhibitors and their…
The RELEVENT trial is a clinical study designed to assess the efficacy and safety of combining ramucirumab with chemotherapy as a first-line treatment for patients…
Colorectal cancer is one of the leading causes of cancer-related deaths worldwide, and early detection is crucial for improving survival rates. Traditional noninvasive screening methods…
The KEYNOTE-522 trial is a significant study in the field of oncology, particularly for the treatment of early triple-negative breast cancer (TNBC), a subtype of…
Immunotherapy has become a significant player in treating various cancers, including endometrial cancer. The use of immune checkpoint inhibitors, which help the immune system recognize…
This information will be used to contact you